|
|
| |
 |
Laboratory-acquired vaccinia virus infection: Virginia, 2008
|
|
 |
Live variola virus: considerations for continuing research
Institute of Medicine report released July 10
|
|
 |
The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks
From Jul Expert Rev Vaccines
|
|
 |
Progressive vaccinia in a military smallpox vaccinee--United States, 2009
Early release from MMWR, published online May 19
|
|
 |
Non-human primates are protected from smallpox virus or monkeypox virus challenges by the antiviral drug ST-246
From Antimicrob Agents Chemother, published online Apr 6
|
|
 |
Evaluation of smallpox vaccines using variola neutralization
From J Gen Virol, published online Apr 1
|
|
 |
Natural human infections with vaccinia virus during bovine vaccinia outbreaks
|
|
 |
Clinical and immunological response to attenuated tissue-cultured smallpox vaccine LC16m8
|
|
 |
Smallpox virus plaque phenotypes: genetic, geographical, and case fatality relationships
From J Gen Virol, published online Mar 4
|
|
 |
Cutting edge: mucosal application of a lyophilized viral vector vaccine confers systemic and protective immunity toward intracellular pathogens
|
|
 |
In vitro efficacy of ST-246 against smallpox and monkeypox
From Mar Antimicrob Agents Chemother
|
|
 |
ST-246 antiviral efficacy in a non-human primate monkeypox model: determination of the minimal effective dose and human dose justification
From Antimicrob Agents Chemother, published online Feb 17
|
|
 |
CDC interim guidance for revaccination of eligible persons who participated in the US civilian smallpox preparedness and response program
CDC document released Jan 15 (but dated Oct 2008)
|
|
 |
A novel replication-competent vaccinia vector MVTT is superior to MVA for inducing high levels of neutralizing antibody via mucosal vaccination
From PLoS ONE, published online Jan 9
|
|
 |
Demographic and clinical factors associated with response to smallpox vaccine in preimmunized volunteers
|
|
 |
Smallpox: Current, comprehensive information on pathogenesis, microbiology, epidemiology, diagnosis, treatment, and prophylaxis
CIDRAP-authored overview, updated Dec 30 with new research
|
|
 |
Coadministration of cidofovir and smallpox vaccine reduced vaccination side effects but interfered with vaccine-elicited responses and immunity to monkeypox
|
|
 |
Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: an investigation of potential fomites in the home environment
|
|
 |
Encephalitis after secondary smallpox vaccination
|
|
 |
ST246 in vitro efficacy against smallpox and monkeypox
From Antimicrob Agents Chemother, published online Dec 15
|
|
 |
Immunity from smallpox vaccine persists for decades: a longitudinal study
|
|
 |
Detection of human orthopoxvirus infections and differentiation of smallpox virus with real-time PCR
From J Med Virol, published online Nov 21
|
|
 |
Smallpox revaccination of 21000 first responders in Israel: lessons learned
From Int J Infect Dis, published online Nov 17
|
|